Activity Release Date: February 9, 2022 Expiration Date: February 9, 2024
This module focuses on enhancing organizational capacity and provider readiness to treat opioid use disorder with buprenorphine-naloxone through reviewing how to recognize and diagnose OUD and differing treatment methodologies.
Learning Objectives
- Detail how to treat OUD with buprenorphine/naloxone
- List at least two justifications for the use of combination buprenorphine/naloxone as the standard of care for general use
- List at least three methods for establishing community partnerships and promoting MOUD services in general medical settings
- Describe the key principles of the medication first model
- Discuss the benefit of adding psychosocial support to the treatment of patients receiving MOUD
- Employ appropriate urine toxicology strategies
- Outline treatment considerations for patients with co-occurring psychiatric disorders
- Explain how to conduct a Telehealth session for treatment of OUDs
Note:
Jointly provided by Postgraduate Institute for Medicine and HealthHIV
Estimated time to complete activity: 1.25 hours
Audience: Providers
Credits Available: AMA, AAPA, ANCC, ASWB, ACPE, CPH
UAN #JA4008162-9999-22-059-H04-P
Activity Type - Knowledge
